Ranbaxy recalls nearly 30,000 packs of allergy-relief drug in U.S

(Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

Click here to read more.